ReP USP - Resultado da busca

Artigo de periodico
Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life (2016)
Borges, Igor C; Andrade, Dafne C; Cardoso, Maria Regina Alves; Toppari, Jorma; Vähä-Mäkilä, Mari; Ilonen, Jorma; Knip, Mikael; Hyöty, Heikki; Veijola, Riitta; Simell, Olli; Jartti, Tuomas; Käyhty, Helena; Ruuskanen, Olli; Nascimento-Carvalho, Cristiana M.
Source: Clinical and Vaccine Immunology. Unidade: FSP
Subjects: STREPTOCOCCUS PNEUMONIAE, ANTÍGENOS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Igor C et al. Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life. Clinical and Vaccine Immunology, v. 23, n. 11, p. 878-883, 2016Tradução . . Disponível em: https://doi.org/10.1128/cvi.00341-16. Acesso em: 04 nov. 2024.
APA
Borges, I. C., Andrade, D. C., Cardoso, M. R. A., Toppari, J., Vähä-Mäkilä, M., Ilonen, J., et al. (2016). Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life. Clinical and Vaccine Immunology, 23( 11), 878-883. doi:10.1128/cvi.00341-16
NLM
Borges IC, Andrade DC, Cardoso MRA, Toppari J, Vähä-Mäkilä M, Ilonen J, Knip M, Hyöty H, Veijola R, Simell O, Jartti T, Käyhty H, Ruuskanen O, Nascimento-Carvalho CM. Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life [Internet]. Clinical and Vaccine Immunology. 2016 ;23( 11): 878-883.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/cvi.00341-16
Vancouver
Borges IC, Andrade DC, Cardoso MRA, Toppari J, Vähä-Mäkilä M, Ilonen J, Knip M, Hyöty H, Veijola R, Simell O, Jartti T, Käyhty H, Ruuskanen O, Nascimento-Carvalho CM. Natural Development of Antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Protein Antigens during the First 13 Years of Life [Internet]. Clinical and Vaccine Immunology. 2016 ;23( 11): 878-883.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/cvi.00341-16
Artigo de periodico
Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen (2016)
Alves, Rúbens Prince dos Santos; Pereira, Lennon Ramos; Fabris, Denicar Lina Nascimento; Salvador, Felipe Scassi; Santos, Robert Andreata; Zanotto, Paolo Marinho de Andrade ; Romano, Camila Malta; Amorim, Jaime Henrique; Ferreira, Luís Carlos de Souza
Source: Clinical and Vaccine Immunology. Unidade: ICB
Subjects: VÍRUS DA DENGUE, ANTÍGENOS DE VÍRUS, ANTICORPOS, DENGUE, VACINAS VIRAIS, EPITOPOS, ESCHERICHIA COLI, IMUNOLOGIA CELULAR, PROTEÍNAS RECOMBINANTES, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Rúbens Prince dos Santos et al. Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen. Clinical and Vaccine Immunology, v. 23, n. 6, p. 460-469, 2016Tradução . . Disponível em: https://doi.org/10.1128/CVI.00081-16. Acesso em: 04 nov. 2024.
APA
Alves, R. P. dos S., Pereira, L. R., Fabris, D. L. N., Salvador, F. S., Santos, R. A., Zanotto, P. M. de A., et al. (2016). Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen. Clinical and Vaccine Immunology, 23( 6), 460-469. doi:10.1128/CVI.00081-16
NLM
Alves RP dos S, Pereira LR, Fabris DLN, Salvador FS, Santos RA, Zanotto PM de A, Romano CM, Amorim JH, Ferreira LC de S. Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen [Internet]. Clinical and Vaccine Immunology. 2016 ; 23( 6): 460-469.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/CVI.00081-16
Vancouver
Alves RP dos S, Pereira LR, Fabris DLN, Salvador FS, Santos RA, Zanotto PM de A, Romano CM, Amorim JH, Ferreira LC de S. Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen [Internet]. Clinical and Vaccine Immunology. 2016 ; 23( 6): 460-469.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/CVI.00081-16
Artigo de periodico
Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin (2013)
Leal, Monica Teixeira Andrade; Camacho, Ariane Guglielmi Ariza; Teixeira, Laís Helena; Bargieri, Daniel Youssef ; Soares, Irene da Silva ; Tararam, Cibele Aparecida; Rodrigues, Mauricio Martins
Source: Clinical and Vaccine Immunology. Unidade: FCF
Subjects: MALÁRIA, VACINAS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Monica Teixeira Andrade et al. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin. Clinical and Vaccine Immunology, v. 20, n. 9, p. 1418-1425, 2013Tradução . . Disponível em: https://doi.org/10.1128/CVI.00312-13. Acesso em: 04 nov. 2024.
APA
Leal, M. T. A., Camacho, A. G. A., Teixeira, L. H., Bargieri, D. Y., Soares, I. da S., Tararam, C. A., & Rodrigues, M. M. (2013). Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin. Clinical and Vaccine Immunology, 20( 9), 1418-1425. doi:10.1128/CVI.00312-13
NLM
Leal MTA, Camacho AGA, Teixeira LH, Bargieri DY, Soares I da S, Tararam CA, Rodrigues MM. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin [Internet]. Clinical and Vaccine Immunology. 2013 ; 20( 9): 1418-1425.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/CVI.00312-13
Vancouver
Leal MTA, Camacho AGA, Teixeira LH, Bargieri DY, Soares I da S, Tararam CA, Rodrigues MM. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica serovar tTyphimurium flagellin [Internet]. Clinical and Vaccine Immunology. 2013 ; 20( 9): 1418-1425.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/CVI.00312-13
Artigo de periodico
Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis (2013)
Tiburcio, Monique Gomes Salles; Anversa, Laís; Kanunfre, Kelly Aparecida; Ferreira, Antonio Walter; Rodrigues Júnior, Virmondes; Silva, Luciana de Almeida
Source: Clinical and Vaccine Immunology. Unidades: FM, IMT
Subjects: LEISHMANIOSE VISCERAL (TERAPIA;IMUNOLOGIA), DOENÇA CRÔNICA, ANTICORPOS, DOENÇAS INFECCIOSAS (IMUNOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIBURCIO, Monique Gomes Salles et al. Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis. Clinical and Vaccine Immunology, v. 20, n. 11, p. 1697-1702, 2013Tradução . . Disponível em: https://doi.org/10.1128/CVI.00367-13. Acesso em: 04 nov. 2024.
APA
Tiburcio, M. G. S., Anversa, L., Kanunfre, K. A., Ferreira, A. W., Rodrigues Júnior, V., & Silva, L. de A. (2013). Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis. Clinical and Vaccine Immunology, 20( 11), 1697-1702. doi:10.1128/CVI.00367-13
NLM
Tiburcio MGS, Anversa L, Kanunfre KA, Ferreira AW, Rodrigues Júnior V, Silva L de A. Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis [Internet]. Clinical and Vaccine Immunology. 2013 ; 20( 11): 1697-1702.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/CVI.00367-13
Vancouver
Tiburcio MGS, Anversa L, Kanunfre KA, Ferreira AW, Rodrigues Júnior V, Silva L de A. Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis [Internet]. Clinical and Vaccine Immunology. 2013 ; 20( 11): 1697-1702.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/CVI.00367-13
Artigo de periodico
Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC (2012)
Moreno, Adriana Tonet; Oliveira, Maria Leonor Sarno de; Ho, Paulo Lee; Vadesilho, Cintia Fiuza Marques; Palma, Giovana M. P; Ferreira Junior, Jorge Mario da Costa; Ferreira, Daniela Mulari; Santos, Silvia Regina Cavani Jorge ; Martinez, Marina Baquerizo; Miyaji, Eliane Namie
Source: Clinical and Vaccine Immunology. Unidade: FCF
Subjects: STREPTOCOCCUS, ANTICORPOS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Adriana Tonet et al. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clinical and Vaccine Immunology, v. 19, n. 4, p. 499-507 : + Supplementary materials, 2012Tradução . . Disponível em: https://doi.org/10.1128/cvi-05706-11. Acesso em: 04 nov. 2024.
APA
Moreno, A. T., Oliveira, M. L. S. de, Ho, P. L., Vadesilho, C. F. M., Palma, G. M. P., Ferreira Junior, J. M. da C., et al. (2012). Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clinical and Vaccine Immunology, 19( 4), 499-507 : + Supplementary materials. doi:10.1128/cvi-05706-11
NLM
Moreno AT, Oliveira MLS de, Ho PL, Vadesilho CFM, Palma GMP, Ferreira Junior JM da C, Ferreira DM, Santos SRCJ, Martinez MB, Miyaji EN. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC [Internet]. Clinical and Vaccine Immunology. 2012 ; 19( 4): 499-507 : + Supplementary materials.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/cvi-05706-11
Vancouver
Moreno AT, Oliveira MLS de, Ho PL, Vadesilho CFM, Palma GMP, Ferreira Junior JM da C, Ferreira DM, Santos SRCJ, Martinez MB, Miyaji EN. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC [Internet]. Clinical and Vaccine Immunology. 2012 ; 19( 4): 499-507 : + Supplementary materials.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1128/cvi-05706-11
Artigo de periodico
Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis (2009)
Yoshida, Márcia; Sanchez, Maria Carmen Arroyo; Shikanai-Yasuda, Maria Aparecida
Source: Clinical and Vaccine Immunology. Unidades: FM, IMT
Subjects: IMUNOGLOBULINAS, ANTICORPOS, PARACOCCIDIOIDES BRASILIENSIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOSHIDA, Márcia e SANCHEZ, Maria Carmen Arroyo e SHIKANAI-YASUDA, Maria Aparecida. Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis. Clinical and Vaccine Immunology, v. 16, n. 11, p. 1583-1586, 2009Tradução . . Disponível em: http://cdli.asm.org/cgi/reprint/16/11/1583. Acesso em: 04 nov. 2024.
APA
Yoshida, M., Sanchez, M. C. A., & Shikanai-Yasuda, M. A. (2009). Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis. Clinical and Vaccine Immunology, 16( 11), 1583-1586. Recuperado de http://cdli.asm.org/cgi/reprint/16/11/1583
NLM
Yoshida M, Sanchez MCA, Shikanai-Yasuda MA. Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis [Internet]. Clinical and Vaccine Immunology. 2009 ; 16( 11): 1583-1586.[citado 2024 nov. 04 ] Available from: http://cdli.asm.org/cgi/reprint/16/11/1583
Vancouver
Yoshida M, Sanchez MCA, Shikanai-Yasuda MA. Increased immunoglobulin G anti-Paracoccidioides brasiliensis serum antibody avidity as a predictor of favorable posttherapeutic evolution in paracoccidioidomycosis [Internet]. Clinical and Vaccine Immunology. 2009 ; 16( 11): 1583-1586.[citado 2024 nov. 04 ] Available from: http://cdli.asm.org/cgi/reprint/16/11/1583

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation